Liliana A. Monasterolo
National Scientific and Technical Research Council
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Liliana A. Monasterolo.
Nephron Experimental Nephrology | 2009
Sara M. Molinas; Cesar Cortés-González; Yvett González-Bobadilla; Liliana A. Monasterolo; Cristino Cruz; María Mónica Elías; Norma A. Bobadilla; Laura Trumper
Background/Aims: Contributions to the understanding of acute renal failure (ARF) pathogenesis have not been translated into an effective clinical therapy. We studied the effects of pretreatment with the angiotensin II type 1 (AT1) receptor blocker, losartan, on renal function, tissue injury, inflammatory response and serum aldosterone levels in a model of ischemic ARF. Methods: Rats underwent unilateral renal ischemia followed by 24 h of reperfusion (IR), and were pretreated or not with 8 (IRL8) or 80 (IRL80) mg/kg/day of losartan for 3 days. Results: IR kidneys showed marked renal dysfunction, epithelial damage, capillary congestion, increased myeloperoxidase (MPO) activity and increased TNF-α, IL1-β and IL-6 mRNA levels. IRL80 kidneys showed protection against dysfunction and tissue injury, associated with normal MPO activity and cytokine mRNA levels. The lower dose was not able to achieve the same degree of functional renoprotection and could not prevent an increase of MPO or proinflammatory cytokine mRNA levels. The high losartan dose completely prevented an increase of serum aldosterone levels induced by IR. Conclusion: Renoprotection of the high losartan dose would be mainly mediated by its anti-inflammatory actions. Our results show a potential pathophysiological role of AT1 activation in promoting renal dysfunction, structural injury, inflammation and aldosterone elevation after IR injury.
Archives of Toxicology | 1995
Laura Trumper; Liliana A. Monasterolo; Elena J. Ochoa; M. Mónica Elías
AbstractThe effects of different acetaminophen (APAP) concentrations (1,5 or 10 mM) on renal function were investigated in the isolated perfused rat kidney (IPK). APAP was added to the perfusion media as a single dose after a equilibration time and control periods. Changes in fractional excretion of sodium (FENa), water
Renal Failure | 1993
Liliana A. Monasterolo; Adriana Peiretti; M. Mónica Elías
Molecular and Cellular Endocrinology | 2011
Melina A. Pagotto; María L. Roldán; Romina Pagotto; María Cristina Lugano; Gerardo B. Pisani; Gastón Rogic; Sara M. Molinas; Laura Trumper; Omar P. Pignataro; Liliana A. Monasterolo
\left( {FE_{H_2 O} } \right)
European Journal of Pharmacology | 2013
Verónica Donato; Gerardo B. Pisani; Laura Trumper; Liliana A. Monasterolo
The Journal of Physiology | 2014
Liliana A. Monasterolo
, glucose (FEglu) and in glomerular filtration rate (GFR) were measured. The lower concentration used only modified the
European Journal of Pharmacology | 2002
Liliana A. Monasterolo; Laura Trumper; M. Mónica Elías
European Journal of Pharmacology | 1995
Liliana A. Monasterolo; J. Elena Ochoa; Laura Trumper; M. Mónica Elías
FE_{H_2 O}
Renal Failure | 2002
Liliana A. Monasterolo; J. Elena Ochoa; María Mónica Elías
European Journal of Pharmacology | 1991
Jose A. Apud; Liliana A. Monasterolo
. APAP 10 mM induced an increment in